Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)

SHE:002589 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,665	4,444	4,920	6,165	5,881	7,826
Market Cap Growth	-5.15%	-9.67%	-20.19%	4.83%	-24.86%	-31.99%
Enterprise Value	6,719	7,022	3,501	7,785	11,382	10,805
Last Close Price	3.10	2.97	3.24	4.08	3.89	5.15
PE Ratio	238.02	215.52	242.17	-	44.83	29.95
Forward PE	-	8.02	8.02	8.02	8.45	12.23
PS Ratio	0.61	0.56	0.61	0.50	0.28	0.29
PB Ratio	0.82	0.78	0.87	1.07	0.61	0.74
P/TBV Ratio	0.95	0.90	1.04	1.33	0.91	1.23
P/FCF Ratio	34.71	90.86	-	17.51	-	-
P/OCF Ratio	18.11	27.70	59.67	11.79	13.28	18.86
PEG Ratio	-	0.36	0.36	0.36	0.36	0.36
EV/Sales Ratio	0.87	0.88	0.44	0.63	0.54	0.40
EV/EBITDA Ratio	40.11	36.51	26.75	46.91	10.22	6.31
EV/EBIT Ratio	-	228.27	-	-	13.99	7.60
EV/FCF Ratio	50.00	143.54	-	22.11	-	-
Debt / Equity Ratio	1.20	1.16	1.21	0.70	0.47	0.96
Debt / EBITDA Ratio	40.89	33.65	50.40	22.86	4.01	5.87
Debt / FCF Ratio	50.97	134.50	-	11.37	-	-
Asset Turnover	0.49	0.49	0.46	0.55	0.72	0.84
Inventory Turnover	8.19	7.66	6.96	7.07	6.92	6.80
Quick Ratio	1.04	1.03	0.96	0.93	1.08	1.06
Current Ratio	1.12	1.12	1.07	1.03	1.25	1.25
Return on Equity (ROE)	0.74%	0.72%	0.56%	-22.52%	3.78%	6.02%
Return on Assets (ROA)	0.06%	0.12%	-0.30%	-0.30%	1.74%	2.75%
Return on Capital (ROIC)	0.09%	0.15%	-0.47%	-0.57%	2.92%	4.75%
Return on Capital Employed (ROCE)	0.30%	0.50%	-	-	8.20%	13.00%
Earnings Yield	0.42%	0.46%	0.41%	-29.70%	2.23%	3.34%
FCF Yield	2.88%	1.10%	-4.39%	5.71%	-0.31%	-2.88%
Dividend Yield	0.26%	0.37%	0.40%	-	0.23%	0.35%
Payout Ratio	1042.99%	963.58%	992.70%	-	241.13%	132.63%
Buyback Yield / Dilution	-0.27%	-0.01%	-1.93%	-1.30%	-0.40%	2.99%
Total Shareholder Return	-0.01%	0.36%	-1.53%	-1.30%	-0.17%	3.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.